These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 9226005)

  • 61. Comparative replication capacity of raltegravir-resistant strains and antiviral activity of the new-generation integrase inhibitor dolutegravir in human primary macrophages and lymphocytes.
    Pollicita M; Surdo M; Di Santo F; Cortese MF; Fabeni L; Fedele V; Malet I; Marcelin AG; Calvez V; Ceccherini-Silberstein F; Perno CF; Svicher V
    J Antimicrob Chemother; 2014 Sep; 69(9):2412-9. PubMed ID: 24860155
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Liposome-mediated delivery of antiviral agents to human immunodeficiency virus-infected cells.
    Düzgüneş N; Pretzer E; Simões S; Slepushkin V; Konopka K; Flasher D; de Lima MC
    Mol Membr Biol; 1999; 16(1):111-8. PubMed ID: 10332745
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Design and synthesis of α-carboxy nucleoside phosphonate analogues and evaluation as HIV-1 reverse transcriptase-targeting agents.
    Keane SJ; Ford A; Mullins ND; Maguire NM; Legigan T; Balzarini J; Maguire AR
    J Org Chem; 2015 Mar; 80(5):2479-93. PubMed ID: 25532055
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Chemotherapy of the acquired immune deficiency syndrome (AIDS): non-nucleoside inhibitors of the human immunodeficiency virus type 1 reverse transcriptase.
    De Clercq E
    Int J Immunopharmacol; 1991; 13 Suppl 1():83-9. PubMed ID: 1726686
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Evaluation of antiretroviral drug efficacy for HIV-1 encephalitis in SCID mice.
    Limoges J; Persidsky Y; Poluektova L; Rasmussen J; Ratanasuwan W; Zelivyanskaya M; McClernon DR; Lanier ER; Gendelman HE
    Neurology; 2000 Jan; 54(2):379-89. PubMed ID: 10668699
    [TBL] [Abstract][Full Text] [Related]  

  • 66. In vitro anti-HIV activity of oleanolic acid on infected human mononuclear cells.
    Mengoni F; Lichtner M; Battinelli L; Marzi M; Mastroianni CM; Vullo V; Mazzanti G
    Planta Med; 2002 Feb; 68(2):111-4. PubMed ID: 11859458
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Differential regulatory activities of viral protein X for anti-viral efficacy of nucleos(t)ide reverse transcriptase inhibitors in monocyte-derived macrophages and activated CD4(+) T cells.
    Hollenbaugh JA; Schader SM; Schinazi RF; Kim B
    Virology; 2015 Nov; 485():313-21. PubMed ID: 26319213
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Inhibition of human immunodeficiency virus type 1 replication in cytokine-stimulated monocytes/macrophages by combination therapy.
    Rusconi S; Merrill DP; Hirsch MS
    J Infect Dis; 1994 Dec; 170(6):1361-6. PubMed ID: 7527825
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Nanogel-Conjugated Reverse Transcriptase Inhibitors and Their Combinations as Novel Antiviral Agents with Increased Efficacy against HIV-1 Infection.
    Senanayake TH; Gorantla S; Makarov E; Lu Y; Warren G; Vinogradov SV
    Mol Pharm; 2015 Dec; 12(12):4226-36. PubMed ID: 26565115
    [TBL] [Abstract][Full Text] [Related]  

  • 70. HIV inhibitors targeted at the reverse transcriptase.
    De Clercq E
    AIDS Res Hum Retroviruses; 1992 Feb; 8(2):119-34. PubMed ID: 1371690
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Evaluation of mutations that confer resistance to nucleoside analogs and protease inhibitors in HIV-1-infected patients. Study Group on Resistance to Antiretroviral Agents].
    Martínez G; Sarría L; Campelo C; Merchán A; Cisterna R
    Rev Esp Quimioter; 1999 Dec; 12(4):317-24. PubMed ID: 10855010
    [TBL] [Abstract][Full Text] [Related]  

  • 72. 9-Nitrocamptothecin inhibits HIV-1 replication in human peripheral blood lymphocytes: a potential alternative for HIV-infection/AIDS therapy.
    Hung CL; Doniger J; Palini A; Snyder SW; Radonovich MF; Brady JN; Pantazis P; Sadaie MR
    J Med Virol; 2001 Jul; 64(3):238-44. PubMed ID: 11424110
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Inhibition of HIV-1 replication in macrophages by a heterodinucleotide of lamivudine and tenofovir.
    Rossi L; Franchetti P; Pierigé F; Cappellacci L; Serafini S; Balestra E; Perno CF; Grifantini M; Caliò R; Magnani M
    J Antimicrob Chemother; 2007 Apr; 59(4):666-75. PubMed ID: 17327293
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Chronically HIV-1 infected human monocyte culture U937 as a model for assessing the efficacy of anti-HIV agents].
    Pokrovskiĭ AG; Pliasunova OA; Gashnikova NM; Mamaeva OA; Fediuk NV
    Vopr Virusol; 2001; 46(6):38-42. PubMed ID: 11785387
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A simple and rapid method for preliminary evaluation of in vivo efficacy of anti-HIV compounds in mice.
    Sato A; Kodama M; Abe K; Miki S; Nishimura M; Suyama A; Ogata M; Toyoda T; Sugimoto H; Yoshie O
    Antiviral Res; 1995 May; 27(1-2):151-63. PubMed ID: 7486952
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Inhibition of visna virus replication by 2',3'-dideoxynucleosides and acyclic nucleoside phosphonate analogs.
    Thormar H; Balzarini J; Holy A; Jindrich J; Rosenberg I; Debyser Z; Desmyter J; De Clercq E
    Antimicrob Agents Chemother; 1993 Dec; 37(12):2540-4. PubMed ID: 7509142
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Aspirin-like molecules that inhibit human immunodeficiency virus 1 replication.
    Pereira CF; Paridaen JT; Rutten K; Huigen MC; van de Bovenkamp M; Middel J; Beerens N; Berkhout B; Schuurman R; Marnett LJ; Verhoef J; Nottet HS
    Antiviral Res; 2003 May; 58(3):253-63. PubMed ID: 12767473
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Inhibition of HIV replication by A77 1726, the active metabolite of leflunomide, in combination with pyrimidine nucleoside reverse transcriptase inhibitors.
    Hossain MM; Margolis DM
    J Acquir Immune Defic Syndr; 2001 Oct; 28(2):199-201. PubMed ID: 11588518
    [No Abstract]   [Full Text] [Related]  

  • 79. A critical subset model provides a conceptual basis for the high antiviral activity of major HIV drugs.
    Shen L; Rabi SA; Sedaghat AR; Shan L; Lai J; Xing S; Siliciano RF
    Sci Transl Med; 2011 Jul; 3(91):91ra63. PubMed ID: 21753122
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A novel approach to develop anti-HIV drugs: adapting non-nucleoside anticancer chemotherapeutics.
    Sadaie MR; Mayner R; Doniger J
    Antiviral Res; 2004 Jan; 61(1):1-18. PubMed ID: 14670589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.